SPONSOR
Hospital General Universitario Gregorio Marañon
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Metabolic Dysfunction-Associated Steatotic Liver DiseaseLiver FibrosisNon-alcoholic Fatty Liver Disease NAFLDType 2 Diabetes MellitusObesityObesity Type 2 Diabetes MellitusSystemic Inflammatory Response Syndrome
Hospital General Universitario Gregorio Marañon is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis, Non-alcoholic Fatty Liver Disease NAFLD, Type 2 Diabetes Mellitus.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Hospital General Universitario Gregorio Marañon
How many clinical trials has Hospital General Universitario Gregorio Marañon sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Hospital General Universitario Gregorio Marañon, of which 2 are actively recruiting participants. These trials cover conditions including Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis, Non-alcoholic Fatty Liver Disease NAFLD. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Hospital General Universitario Gregorio Marañon research focus on?
Hospital General Universitario Gregorio Marañon clinical trials span Metabolic Dysfunction-Associated Steatotic Liver Disease, Liver Fibrosis, Non-alcoholic Fatty Liver Disease NAFLD, Type 2 Diabetes Mellitus, Obesity, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Hospital General Universitario Gregorio Marañon clinical trial?
To participate in a Hospital General Universitario Gregorio Marañon trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Hospital General Universitario Gregorio Marañon trials with current recruitment status updated daily.
Clinical Trials by Hospital General Universitario Gregorio Marañon
NCT07658755
Recruiting
Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme
Metabolic Dysfunction-Associated Steatotic Liver Disease
NCT06052436 Phase 1, Phase 2
Recruiting
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
Systemic Inflammatory Response Syndrome
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology